Corporate Snapshot – Advasa (ADBT)

  • Trading status Advasa closed the latest 24‑hour session unchanged at USD 0.11. The share price has been flat (0 %) through Friday, 23 Oct 2026, at 11:23 AM Central Europe.

  • Supply and capitalization Outstanding shares total 504.8 million. With the current price, the market capitalization sits at USD 55.5 million.

  • Volume In the last day, approximately USD 278.4 k of Advasa shares were exchanged on the open market.

  • Recent performance From the close of the previous month, Advasa has fallen ‑8.33 %. Its 200‑day simple moving average is USD 0.90, suggesting a long‑term downward bias. The 52‑week high reached USD 13.20 on 25 Aug 2026, while the 52‑week low dipped to USD 0.09 on 14 Sep 2026.

  • Peer context (last 24 h)

  • Rank One Computing (ROC): down 0.55 %, trading at USD 3.49 (market cap USD 66.6 mn).

  • Electrocore (ECOR): down 1.87 %, trading at USD 7.41 (market cap USD 66.3 mn).

  • Lanzatech Global (LNZA): down 0.99 %, trading at USD 4.98 (market cap USD 65.5 mn); P/E 0.33.

  • Fortress Biotech (FBIO): up 2.58 %, trading at USD 1.99 (market cap USD 64.7 mn); P/E 0.73.

  • Optex (OPXS): down 1.44 %, trading at USD 9.56 (market cap USD 66.5 mn); P/E 14.97.

These metrics provide a concise, data‑driven overview of Advasa’s current standing and how it compares to its immediate peers. The flat price action and declining trend suggest a cautious outlook, while the broader sector movements offer potential context for strategic positioning.